New Combined Therapy Helps Extend Liv... - Prostate Cancer N...

Prostate Cancer Network

4,944 members3,079 posts

New Combined Therapy Helps Extend Lives of Men With Prostate Cancer

Yearofthecow profile image
3 Replies

"Cedars-Sinai Cancer Study Shows Hormone Therapy, Plus Pelvic Lymph Node Treatment, Improves Survival

Practice-changing research from Cedars-Sinai Cancer shows that a combination of androgen deprivation therapy—a commonly used hormone injection—plus pelvic lymph node radiation, kept nearly 90% of clinical trial patients’ prostate cancer at bay for five years. The findings were published in the peer-reviewed journal The Lancet.

The study also shows that patients with prostate cancer who didn’t receive androgen deprivation therapy—and who did not receive pelvic lymph node radiation—had a five-year survival of 70%."

cedars-sinai.org/newsroom/n...

"In men with a detectable prostate-specific antigen (PSA) level after prostatectomy for prostate cancer, salvage prostate bed radiotherapy (PBRT) results in about 70% of patients being free of progression at 5 years. A three-group randomised trial was designed to determine whether incremental gains in patient outcomes can be achieved by adding either 4–6 months of short-term androgen deprivation therapy (ADT) to PBRT, or both short-term ADT and pelvic lymph node radiotherapy (PLNRT) to PBRT."

..............

"The results of this randomised trial establish the benefit oadding short-term ADT to PBRT to prevent progression in prostate cancer. To our knowledge, these are the first such findings to show that extending salvage radiotherapy to treat the pelvic lymph nodes when combined with short-term ADT results in meaningful reductions in progression after prostatectomy in patients with prostate cancer."

thelancet.com/journals/lanc...

Written by
Yearofthecow profile image
Yearofthecow
To view profiles and participate in discussions please or .
Read more about...
3 Replies
Justfor_ profile image
Justfor_

Quoting from the link:

"...However, late toxicity (>3 months after radiotherapy) did not differ significantly between the groups, apart from more late grade 2 or worse blood or bone marrow events in group 3 versus group 2 (one-sided p=0·0060) attributable to the addition of PLNRT in this group."

No free lunch here.

Yearofthecow profile image
Yearofthecow in reply to Justfor_

No free lunch, but it significantly keeps things contained

julianc profile image
julianc

Thanks for posting this, very useful study as I consider my options for SRT.

You may also like...

Timing of Androgen Deprivation Treatment for Men with Biochemical Recurrent Prostate Cancer in the Context of Novel Therapies

with biochemically recurrent prostate cancer, who defer hormone therapy until metastasis have...

Amar Kishan, MD, on Optimal Sequencing of ADT With RT in Nonmetastatic Prostate Cancer

\\"For patients with nonmetastatic prostate cancer, the optimal sequencing of short-term...

Brief, intense radiation and hormone therapy for very high risk prostate cancer

Another trial suggests that SBRT may be as good as brachy boost therapy for very high risk...

New to the prostate cancer community

diagnosed with prostate cancer. A rise in PSA from 5.4 to 7.4 plus a bump felt on my prostate led...

Short-term vs Long-Term ADT for High Risk Men

ong-term-androgen-deprivation-therapy-with-radiotherapy-in-men-with-localized-high-risk-prostate-can